|
US6355653B1
(en)
|
1999-09-06 |
2002-03-12 |
Hoffmann-La Roche Inc. |
Amino-triazolopyridine derivatives
|
|
SI1283839T1
(https=)
|
2000-05-26 |
2005-08-31 |
Schering Corp |
|
|
ATE273695T1
(de)
|
2000-06-28 |
2004-09-15 |
Smithkline Beecham Plc |
Nassvermahlung
|
|
PE20030739A1
(es)
|
2001-11-30 |
2003-08-28 |
Schering Corp |
Antagonistas del receptor de adenosina a2a
|
|
US7674791B2
(en)
|
2003-04-09 |
2010-03-09 |
Biogen Idec Ma Inc. |
Triazolopyrazines and methods of making and using the same
|
|
JP2005343889A
(ja)
*
|
2004-05-06 |
2005-12-15 |
Taisho Pharmaceut Co Ltd |
イミダゾピリジン誘導体
|
|
ATE482213T1
(de)
*
|
2004-11-04 |
2010-10-15 |
Vertex Pharma |
Als inhibitoren von proteinkinasen geeignete pyrazoloä1,5-aüpyrimidine
|
|
ME02372B
(me)
*
|
2006-11-22 |
2016-06-20 |
Incyte Holdings Corp |
Imidazotriazini i imidazopiramidini kao inhibitori kinaze
|
|
HUP0700395A2
(en)
|
2007-06-07 |
2009-03-02 |
Sanofi Aventis |
Substituted [1,2,4] triazolo [1,5-a] quinolines, process for their preparation, pharmaceutical compositions thereof, and intermediates
|
|
EP3070090B1
(en)
|
2007-06-13 |
2018-12-12 |
Incyte Holdings Corporation |
Use of salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h- pyrazol-1-yl)-3- cyclopentylpropanenitrile
|
|
CL2008001709A1
(es)
|
2007-06-13 |
2008-11-03 |
Incyte Corp |
Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras.
|
|
ES2375425T3
(es)
*
|
2007-07-26 |
2012-02-29 |
Novartis Ag |
Compuestos org�?nicos.
|
|
BRPI0817434A2
(pt)
*
|
2007-10-17 |
2015-06-16 |
Novartis Ag |
Composto orgânicos
|
|
EP2453882A1
(en)
*
|
2009-07-14 |
2012-05-23 |
Beth Israel Deaconess Medical Center, Inc. |
Methods of increasing liver proliferation
|
|
RS54824B1
(sr)
|
2010-05-21 |
2016-10-31 |
Incyte Holdings Corp |
Topikalna formulacija za inhibiciju jak-a
|
|
EP2598505B1
(en)
*
|
2010-07-28 |
2015-03-18 |
Bayer Intellectual Property GmbH |
Substituted imidazo[1,2-b]pyridazines
|
|
EP2463289A1
(en)
|
2010-11-26 |
2012-06-13 |
Almirall, S.A. |
Imidazo[1,2-b]pyridazine derivatives as JAK inhibitors
|
|
CN103649093B
(zh)
|
2011-05-06 |
2017-07-07 |
拜耳知识产权有限责任公司 |
取代的咪唑并吡啶和咪唑并哒嗪及其用途
|
|
KR102092988B1
(ko)
*
|
2012-09-28 |
2020-03-25 |
벤더르빌트 유니버시티 |
선택성 bmp 저해제로써 융합된 헤테로 고리 화합물들
|
|
MX2015005375A
(es)
*
|
2012-11-07 |
2015-07-21 |
Hoffmann La Roche |
Compuestos de triazolo.
|
|
US9682983B2
(en)
*
|
2013-03-14 |
2017-06-20 |
The Brigham And Women's Hospital, Inc. |
BMP inhibitors and methods of use thereof
|
|
EP3365340B1
(en)
|
2015-10-19 |
2022-08-10 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
US20170145025A1
(en)
|
2015-11-19 |
2017-05-25 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
ES2916874T3
(es)
|
2015-12-17 |
2022-07-06 |
Incyte Corp |
Derivados de N-fenil-piridina-2-carboxamida y su uso como moduladores de la interacción proteína/proteína PD-1/PD-L1
|
|
AU2016379372A1
(en)
|
2015-12-22 |
2018-08-02 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
ES2906460T3
(es)
|
2016-05-06 |
2022-04-18 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
|
ES2905980T3
(es)
|
2016-05-26 |
2022-04-12 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
|
BR112018076534A2
(pt)
|
2016-06-20 |
2019-04-02 |
Incyte Corporation |
compostos heterocíclicos como imunomoduladores
|
|
MA45669A
(fr)
|
2016-07-14 |
2019-05-22 |
Incyte Corp |
Composés hétérocycliques utilisés comme immunomodulateurs
|
|
EP3854796A1
(en)
*
|
2016-08-17 |
2021-07-28 |
Children's Hospital Medical Center |
Imidazo[1,2-a]pyridine compounds, compositions comprising them, methods for treating diseases using them, and methods for preparing them
|
|
ES2941716T3
(es)
|
2016-08-29 |
2023-05-25 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
|
JP2019533643A
(ja)
*
|
2016-09-14 |
2019-11-21 |
ヴァンダービルト ユニバーシティーＶａｎｄｅｒｂｉｌｔ Ｕｎｉｖｅｒｓｉｔｙ |
Ｂｍｐシグナル伝達の阻害、その化合物、組成物および使用
|
|
MX2019002951A
(es)
|
2016-09-15 |
2019-09-11 |
Armstrong World Ind Inc |
Sistema de techo con movimiento aereo.
|
|
WO2018119286A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Bicyclic heteroaromatic compounds as immunomodulators
|
|
WO2018119263A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds derivatives as pd-l1 internalization inducers
|
|
ES2874756T3
(es)
|
2016-12-22 |
2021-11-05 |
Incyte Corp |
Derivados de triazolo[1,5-A]piridina como inmunomoduladores
|
|
ES2899402T3
(es)
|
2016-12-22 |
2022-03-11 |
Incyte Corp |
Derivados de piridina como inmunomoduladores
|
|
AU2017382870B2
(en)
|
2016-12-22 |
2022-03-24 |
Incyte Corporation |
Benzooxazole derivatives as immunomodulators
|
|
EP3558990B1
(en)
|
2016-12-22 |
2022-08-10 |
Incyte Corporation |
Tetrahydro imidazo[4,5-c]pyridine derivatives as pd-l1 internalization inducers
|
|
US20200054643A1
(en)
|
2017-01-18 |
2020-02-20 |
Vanderbilt University |
Fused heterocyclic compounds as selective bmp inhibitors
|
|
WO2018165569A1
(en)
*
|
2017-03-10 |
2018-09-13 |
Rutgers, The State University Of New Jersey |
Therapeutic compounds and methods
|
|
CN109963854B
(zh)
|
2017-03-16 |
2022-04-12 |
江苏恒瑞医药股份有限公司 |
杂芳基并[4,3-c]嘧啶-5-胺类衍生物、其制备方法及其在医药上的应用
|
|
RU2019133646A
(ru)
*
|
2017-03-30 |
2021-04-30 |
Ф. Хоффманн-Ля Рош Аг |
Изохинолины в качестве ингибиторов hpk1
|
|
CU20200041A7
(es)
|
2017-10-24 |
2021-03-11 |
Bayer Ag |
Amidas de imidazopiridina sustituidas
|
|
BR122023024273A2
(pt)
|
2018-02-27 |
2024-02-20 |
Incyte Corporation |
Compostos imidazopirimidinas e triazolopirimidinas, seus usos, método para inibir uma atividade de um receptor de adenosina e composição farmacêutica dos mesmos
|
|
CA3124088A1
(en)
|
2018-12-20 |
2020-06-25 |
Incyte Corporation |
Imidazopyridazine and imidazopyridine compounds as inhibitors of activin receptor-like kinase-2
|
|
CN115956081A
(zh)
|
2020-06-12 |
2023-04-11 |
因赛特公司 |
具有作为alk2抑制剂的活性的咪唑并哒嗪化合物
|